Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | YEATS4 | O95619 | 1/20 | 0.38 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PDE2A | O00408 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19396276 | 0.89 | L3MBTL1 (0.51) | ALDH1A1KDM4EGFERLMNAGAA | |
| SCHEMBL19396277 | 0.89 | L3MBTL1 (0.51) | ALDH1A1KDM4EGFERLMNAGAA | |
| SCHEMBL12589846 | 0.89 | L3MBTL1 (0.51) | ALDH1A1KDM4EGFERLMNAGAA | |
| SCHEMBL12589841 | 0.87 | ALDH1A1 (0.46) | ALDH1A1KDM4EGFERLMNAGAA | |
| SCHEMBL1594796 | 0.85 | ALDH1A1 (0.56) | ALDH1A1LMNAGAATSHRNPSR1 | |
| SCHEMBL17624645 | 0.85 | MAPT (0.47) | ALDH1A1KDM4ELMNATSHRNPSR1 | |
| SCHEMBL12589838 | 0.82 | MAPK14 (0.49) | ALDH1A1KDM4ELMNAL3MBTL1MAPK14 | |
| SCHEMBL19396257 | 0.80 | L3MBTL3 (0.62) | ALDH1A1L3MBTL1 | |
| SCHEMBL12589839 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KDM4ELMNAGAATSHR | |
| SCHEMBL19396255 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KDM4EGAATSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170273968-A1 | MAO-B INHIBITORS AND REHABILITATION | DART NEUROSCIENCE, LLC | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170273968-A1 | MAO-B INHIBITORS AND REHABILITATION | MAOB, MAOA, HTR2B | ALDH1A1 1300/4885KDM4E 1355/4885GFER 1291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.